MedTrace Logo

Ketorolac vs. Steroid in the Prevention of CME

NCT00348244 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2007-01-17

No results posted yet for this study

Summary

Evaluate if the incidence of sub clinical CME can be significantly reduced by use of peri-operative Acular LS plus Pred Forte when compared with Pred Forte alone in normal cataract patients.

Conditions

  • Cataract

Interventions

DRUG

Ketorolac, Prednisolone Acetate

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Principal Investigators

  • John Wittpenn, MD · Ophthalmic Consultants of Long Island

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00348244 on ClinicalTrials.gov